Invasive pneumococcal disease among children younger than 5 years of age before and after introduction of pneumococcal conjugate vaccine in Casablanca, Morocco

• Main Authors: Idrissa Diawara, Khalid Zerouali, Khalid Katfy, Bahija Zaki, Houria Belabbes, Jillali Najib, Naima Elmdaghri
• Format: Article
• Language: English
• Published: Elsevier 2015-11-01
• Series: International Journal of Infectious Diseases
• Subjects: Streptococcus pneumoniae; Invasive pneumococcal disease; Pneumococcal conjugate vaccine; Antibiotic resistance
• Online Access: http://www.sciencedirect.com/science/article/pii/S1201971215002295
• ISSN: 1201-9712; 1878-3511

Objectives: The purpose of this study was to compare the incidence rate of invasive pneumococcal disease, the rates of antibiotic resistance and serotype distribution among children ≤5 years old before and after PCVs introduction in Casablanca, Morocco. Methods: This study was conducted at the Ibn Rochd University Hospital Centre of Casablanca during two periods encompassing pre-and post-implementation of PCVs, respectively from January 2007 to October 2010 and from January 2011 to December 2014. All the non-duplicate invasive S. pneumoniae isolates recovered during the study periods were included. Results: There were 136 cases of IPD, 91 before and 45 after PCVs introduction. The greatest decrease in incidence rate of IPD occurred in children ≤ 2 years of age declining from 34.6 to 13.5 per 100,000 populations (p < 0.0001) before and after vaccination, respectively. The incidence rate of PCV-7, PCV-10 non-PCV-7 and PCV-13 non-PCV-10 serotypes decrease significantly from 18.0 to 4.6, from 5.7 to 1.3 and from 5.7 to 0.8/100,000 population (p < 0.001) in the same age, respectively. Conclusion: Shifts in the distribution of IPD serotypes and reductions in the incidence rate of disease suggest an effective reduction of the burden of IPD in children, but continued high quality surveillance is critical to assess the changes in serotype distributions.